Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Simultaneous quantification of high-dose naloxone and naloxone-3-β-d-glucuronide in human plasma by UHPLC-MS/MS

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. The influence of sample collection methodology and sample preprocessing on the blood metabolic profile

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Development of a fast method for direct analysis of intact synthetic insulins in human plasma: the large peptide challenge

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Current strategies in the discovery of small-molecule biomarkers for Alzheimer's disease

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. High-dose naloxone, an experimental tool uncovering latent sensitisation: pharmacokinetics in humans

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A national center for persistent severe pain after groin hernia repair: Five-year prospective data

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Akut och cancerrelaterad smärta: Smärtmedicin

    Publikation: Bog/antologi/afhandling/rapportAntologiForskningpeer review

Vis graf over relationer

AIM: High-dose administration of the μ-opioid receptor inverse agonist naloxone (NX), has previously been demonstrated to reinstate nocifensive behavior in the late phase of inflammatory injuries. However, no current analytical methods can provide pharmacokinetic insight into the pharmacodynamic response of high-dose administration of NX.

MATERIALS & METHODS: Based on protein precipitation using 50 μl human plasma, NX and naloxone-β-d-glucuronide (NXG) was analysed by UHPLC-MS/MS with 6 min cycle time. Results: A method for quantification of high-dose administered NX and NXG was developed and validated with intra- and interday precision and accuracy within ≤8.5% relative standard deviation (RSD) and -1.2-5.5% relative error (RE) for NX and ≤9.6% RSD and 0.6-6.5% RE for NXG. The method show excellent internal standard corrected matrix effects.

CONCLUSION: A rapid UHPLC-MS/MS method was developed for quantification of NX and NXG in human plasma within 10-4000 ng/ml.

OriginalsprogEngelsk
TidsskriftBioanalysis
Vol/bind11
Udgave nummer3
Sider (fra-til)165-173
Antal sider9
ISSN1757-6180
DOI
StatusUdgivet - 2020

ID: 59034960